Dariohealth Corp (DRIO)

Date: O: H: L: C: Vol:

Finanzdaten der Dariohealth Corp-Aktie (DRIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.29%5.18	5.58	5.23	5.01	5.37
Cost Of Revenue	16.74%1.99	2.38	2.43	1.99	2.41
Gross Profit	0.25%3.19	3.20	2.80	3.02	2.96
	7.97%9.67	10.51	11.37	12.50	12.16
Research and Development	11.95%2.10	2.39	2.63	3.33	3.72
Operating Income/Loss	11.36%-6.48	-7.31	-8.56	-9.48	-9.20
Nonoperating Income/Loss	26.50%-1.12	-0.88	-0.39	-0.98	-3.79
Income/Loss From Continuing Operations Before Tax	7.28%-7.60	-8.19	-8.95	-10.47	-12.99
Income Tax Expense/Benefit	475.44%0.33	0.06	0.08	-	0.02
Income/Loss From Continuing Operations After Tax	3.94%7,923.77	8,248.86	9.03	10.47	12.99
	3.94%-7.92	-8.25	-9.03	-10.47	-12.99
Attributable To Parent	3.94%-7.92	-8.25	-9.03	-10.47	-12.99
Basic Average Shares	41.95%9.34	6.58	-	3.14	49.63
Diluted Average Shares	41.95%9.34	6.58	-	3.14	49.63
Basic Earnings Per Share	32.00%0.85	1.25	-	2.96	0.18
Diluted Earnings Per Share	32.00%0.85	1.25	-	2.96	0.18